Document is current
Any future updates will be listed below
-
Authors
Bao, Shengjuan
Chen, Suting
Huang, Hairong
Duan, Hongfei
-
Funding
Funding for this research was provided by:
Chinese Institutes for Medical Research (CX24PY24)
Beijing Public Health Experts Project (G2023-2-002)
R&D Program of Beijing Municipal Education Commission (KZ20231002545)
The Beijing High-Level Public Health Talent Program (G2024-03-08)
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 5 February 2026
First Online: 5 March 2026
Declarations
:
: This study was conducted following the Declaration of Helsinki. The Institutional Review Board of Beijing Chest Hospital, Capital Medical University, approved the protocol (IRB No. YJS-2022-15). This trial was retrospectively registered at ClinicalTrials.gov on November 8, 2024 (Registration number: [ChiCTR2400092512]). All patients who enrolled prospectively in this study provided written informed consent.
: Written informed consent for publication was obtained from the patient(s) (or their legal guardians) from whom the bacterial strains were isolated.
: The authors declare no competing interests.
